TY - JOUR
T1 - A Scoping Review of Pharmacotherapy, Complementary, and Alternative Medicine (CAM), and Surgical Therapies for Androgenic Alopecia
AU - Presley, Colby L.
AU - Kolodziejczyk, Tesia C.
AU - Pulsipher, Kayd J.
AU - Maghfour, Jalal
AU - Militello, Michelle
AU - Rietcheck, Hope R.
AU - Fonseca, Allene
AU - Olayinka, Temitope J.
AU - Rundle, Chandler W.
AU - Waller, Jacquelyn D.
AU - Dellavalle, Robert P.
N1 - Publisher Copyright:
© 2021, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
PY - 2021/6
Y1 - 2021/6
N2 - Purpose of Review: Androgenic alopecia (AGA) is the most common form of non-scarring alopecia, affecting millions of men and women in the United States (U.S.). This review highlights alternative and complementary treatment options for AGA. Recent Findings: The treatment regimens for AGA have increased in pharmacotherapeutics, surgical, and complementary (CAM) categories. Each of the different treatment approaches can now be utilized by dermatologists to combat patient hair loss. Summary: The U.S. Food and Drug Administration (FDA) has approved only two agents to treat AGA: prescription-only, oral finasteride and over-the-counter (OTC), topical minoxidil. Increased availability of therapies claiming hair regrowth properties, coupled with limited pharmacotherapeutic options for AGA, lead patients to seek alternative treatments. Increased awareness of the current evidence supporting complementary and alternative therapies among dermatologists will facilitate appropriate and timely education of AGA patients.
AB - Purpose of Review: Androgenic alopecia (AGA) is the most common form of non-scarring alopecia, affecting millions of men and women in the United States (U.S.). This review highlights alternative and complementary treatment options for AGA. Recent Findings: The treatment regimens for AGA have increased in pharmacotherapeutics, surgical, and complementary (CAM) categories. Each of the different treatment approaches can now be utilized by dermatologists to combat patient hair loss. Summary: The U.S. Food and Drug Administration (FDA) has approved only two agents to treat AGA: prescription-only, oral finasteride and over-the-counter (OTC), topical minoxidil. Increased availability of therapies claiming hair regrowth properties, coupled with limited pharmacotherapeutic options for AGA, lead patients to seek alternative treatments. Increased awareness of the current evidence supporting complementary and alternative therapies among dermatologists will facilitate appropriate and timely education of AGA patients.
KW - Alternative treatment
KW - Androgenic alopecia
KW - Complementary medicine
KW - hair loss
KW - Hair transplant
UR - http://www.scopus.com/inward/record.url?scp=85103423888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103423888&partnerID=8YFLogxK
U2 - 10.1007/s13671-021-00331-8
DO - 10.1007/s13671-021-00331-8
M3 - Review article
AN - SCOPUS:85103423888
SN - 2162-4933
VL - 10
SP - 48
EP - 54
JO - Current Dermatology Reports
JF - Current Dermatology Reports
IS - 2
ER -